Zoetis Inc

Latest Results (18.10.2025):

Zoetis Inc reported strong financial results for the third quarter of 2023, showcasing significant growth in both revenue and net income. The company achieved a reported revenue of $2.2 billion, marking a 7% increase compared to the same quarter last year. Net income rose by 13% to $596 million, or $1.29 per diluted share. Additionally, Zoetis updated its full-year 2023 guidance, reflecting confidence in continued operational growth despite foreign exchange impacts.

Revenue Growth

In Q3 2023, Zoetis Inc generated $2.2 billion in revenue, representing a 7% increase on a reported basis and an 8% growth operationally compared to Q3 2022. The U.S. segment contributed $1.174 billion, while the International segment brought in $956 million, both growing by 8%.

Net Income Increase

Net income for the third quarter reached $596 million, up 13% year-over-year, translating to $1.29 per diluted share. On an adjusted basis, net income was $629 million, or $1.36 per diluted share, showing an 11% increase on a reported basis and 13% operational growth.

Full-Year 2023 Guidance

Zoetis Inc updated its full-year 2023 revenue guidance to a range of $8.475 to $8.550 billion, adjusting for foreign exchange rates. The company also narrowed its operational revenue growth forecast to 6.5%–7.5% and adjusted net income growth to 7.5%–8.5%, reflecting a more precise outlook amidst global economic conditions.

Segment Performance

The companion animal portfolio saw an 11% operational increase, driven by key franchises like dermatology and parasiticides. The livestock portfolio experienced a 3% operational growth, supported by poultry sales and the expanded use of Zoamix®. Internationally, sales of companion animal products grew by 12%, while livestock products in this segment grew by 3% on a reported basis and 5% operationally.

Strategic Investments

Zoetis continued to invest in growth by expanding product claims and launching new products such as Librela® and Apoquel Chewable in the U.S. These efforts support the company's diverse portfolio and drive long-term growth across major markets worldwide.